HOCHDORF Holding AG
HOCHDORF Holding AG: Forward Integration in Baby Care
EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Letter of Intent HOCHDORF Group Press Release: Forward Integration in Baby Care Forward integration with Pharmalys Laboratories SA under examination Hochdorf, 25 July 2016 – HOCHDORF Holding Ltd previously announced the integration of downstream stages of the value creation stream as one of its strategic aims, particularly for the international market. In the area of Baby Care there is now mutual interest with Pharmalys Laboratories SA in pursuing an integration with the HOCHDORF Group. A Memorandum of Understanding has been signed to this effect. HOCHDORF Holding Ltd does not currently supply the end consumer market in the Baby Care area through its subsidiary HOCHDORF Swiss Nutrition Ltd. This would change with a majority shareholding in Pharmalys Laboratories SA, based in Baar (ZG). Active in 42 countries “We have achieved a very rapid growth in recent years with HOCHDORF products and we would like to continue in this vein. An integration can guarantee our access to the high-quality HOCHDORF products. In return HOCHDORF will receive direct access to consumers in our highly attractive markets,” explained founder and CEO of the Pharmalys Group, Amir Mechria. As part of this transaction, HOCHDORF will secure a call option for majority share in the Dubai-based Phamena Ltd, which is also part of the Pharmalys Group. Phamena Ltd operates exclusively in the Libyan market. Dr Thomas Eisenring, CEO of the HOCHDORF Group is delighted with the Memorandum of Understanding: “The HOCHDORF Group is striving towards forward integration in the area of infant nutrition. An association with one of our largest customers is exactly in keeping with our strategy. We have enjoyed excellent collaboration with Pharmalys for years,” he said. The next step will be to negotiate a purchase agreement. Adoption of the purchase agreement will depend on a variety of conditions. It may not be derived from either the Memorandum of Understanding or this press release that HOCHDORF Holding Ltd has acquired a minority or majority shareholding in Pharmalys Laboratories SA either now or in the future. End of ad hoc announcement Additional features: Document: http://n.eqs.com/c/fncls.ssp?u=EFBURFFCIK Document title: HOCHDORF Group Press Release Forward Integration 2016-07-25 News transmitted by Tensid EQS AG. www.eqs.com Information and Explanation of the Issuer to this News: In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a consolidated gross sales revenue of CHF 551.2 million. It is one of the leading foodstuff companies in Switzerland, with more than 625 employees as at 31 December 2015. Made from such natural ingredients as milk, wheat germ, and oilseeds, HOCHDORF products have been contributing to the health and well-being of the young and old alike since 1895. Our customers include the food industry and wholesalers and retailers. Our products are sold in more than 90 countries. HOCHDORF stock is traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528). |
Language: | English | |
Company: | HOCHDORF Holding AG | |
Siedereistrasse 9 | ||
6281 Hochdorf | ||
Switzerland | ||
Phone: | +41 41 914 65 65 | |
Fax: | +41 41 914 66 66 | |
E-mail: | hochdorf@hochdorf.com | |
Internet: | www.hochdorf.com | |
ISIN: | CH0024666528 | |
Listed: | Foreign Exchange(s) SIX | |
End of News | EQS Group News Service |